Back to Search Start Over

Immunodominant Cytomegalovirus Epitopes Suppress Subdominant Epitopes in the Generation of High-Avidity CD8 T Cells.

Authors :
Freitag K
Hamdan S
Reddehase MJ
Holtappels R
Source :
Pathogens (Basel, Switzerland) [Pathogens] 2021 Jul 29; Vol. 10 (8). Date of Electronic Publication: 2021 Jul 29.
Publication Year :
2021

Abstract

CD8 <superscript>+</superscript> T-cell responses to pathogens are directed against infected cells that present pathogen-encoded peptides on MHC class-I molecules. Although natural responses are polyclonal, the spectrum of peptides that qualify for epitopes is remarkably small even for pathogens with high coding capacity. Among those few that are successful at all, a hierarchy exists in the magnitude of the response that they elicit in terms of numbers of CD8 <superscript>+</superscript> T cells generated. This led to a classification into immunodominant and non-immunodominant or subordinate epitopes, IDEs and non-IDEs, respectively. IDEs are favored in the design of vaccines and are chosen for CD8 <superscript>+</superscript> T-cell immunotherapy. Using murine cytomegalovirus as a model, we provide evidence to conclude that epitope hierarchy reflects competition on the level of antigen recognition. Notably, high-avidity cells specific for non-IDEs were found to expand only when IDEs were deleted. This may be a host's back-up strategy to avoid viral immune escape through antigenic drift caused by IDE mutations. Importantly, our results are relevant for the design of vaccines based on cytomegaloviruses as vectors to generate high-avidity CD8 <superscript>+</superscript> T-cell memory specific for unrelated pathogens or tumors. We propose the deletion of vector-encoded IDEs to avoid the suppression of epitopes of the vaccine target.

Details

Language :
English
ISSN :
2076-0817
Volume :
10
Issue :
8
Database :
MEDLINE
Journal :
Pathogens (Basel, Switzerland)
Publication Type :
Academic Journal
Accession number :
34451420
Full Text :
https://doi.org/10.3390/pathogens10080956